CRINETICS PHARMACEUTICALS IN's ticker is CRNX and the CUSIP is 22663K107. A total of 122 filers reported holding CRINETICS PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $959,115 | +107.4% | 32,250 | +25.7% | 0.01% | +100.0% |
| Q2 2023 | $462,483 | +13.4% | 25,665 | +1.0% | 0.00% | 0.0% |
| Q1 2023 | $407,908 | -10.5% | 25,399 | +2.0% | 0.00% | 0.0% |
| Q4 2022 | $455,542 | -7.2% | 24,893 | -0.4% | 0.00% | -25.0% |
| Q3 2022 | $491,000 | +7.0% | 24,984 | +1.4% | 0.00% | +33.3% |
| Q2 2022 | $459,000 | -8.6% | 24,630 | +7.6% | 0.00% | 0.0% |
| Q1 2022 | $502,000 | -27.9% | 22,881 | -6.6% | 0.00% | 0.0% |
| Q4 2021 | $696,000 | +61.5% | 24,492 | +19.6% | 0.00% | +50.0% |
| Q3 2021 | $431,000 | +11.9% | 20,479 | +0.2% | 0.00% | +100.0% |
| Q2 2021 | $385,000 | +59.8% | 20,439 | +29.6% | 0.00% | 0.0% |
| Q1 2021 | $241,000 | +8.6% | 15,771 | +0.3% | 0.00% | 0.0% |
| Q4 2020 | $222,000 | -12.6% | 15,730 | -2.8% | 0.00% | 0.0% |
| Q3 2020 | $254,000 | -12.4% | 16,181 | -2.2% | 0.00% | 0.0% |
| Q2 2020 | $290,000 | +202.1% | 16,549 | +153.2% | 0.00% | 0.0% |
| Q1 2020 | $96,000 | -44.5% | 6,537 | -5.5% | 0.00% | 0.0% |
| Q4 2019 | $173,000 | +64.8% | 6,914 | -0.8% | 0.00% | – |
| Q3 2019 | $105,000 | -40.3% | 6,972 | -0.7% | 0.00% | -100.0% |
| Q2 2019 | $176,000 | +40.8% | 7,022 | +28.2% | 0.00% | – |
| Q1 2019 | $125,000 | -9.4% | 5,478 | +19.5% | 0.00% | -100.0% |
| Q4 2018 | $138,000 | +4.5% | 4,585 | -0.8% | 0.00% | – |
| Q3 2018 | $132,000 | – | 4,620 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 820,720 | $17,276,000 | 7.15% |
| 5AM Venture Management, LLC | 1,362,286 | $28,676,000 | 5.82% |
| Bain Capital Life Sciences Investors, LLC | 1,679,701 | $35,358,000 | 2.19% |
| Opaleye Management Inc. | 402,113 | $8,464,000 | 1.58% |
| FRAZIER MANAGEMENT LLC | 851,306 | $17,920,000 | 1.43% |
| Perceptive Advisors | 3,963,517 | $83,432,000 | 1.21% |
| Altium Capital Management LP | 193,000 | $4,063,000 | 1.07% |
| MPM BioImpact LLC | 298,392 | $6,281,000 | 0.97% |
| SPHERA FUNDS MANAGEMENT LTD. | 548,643 | $11,549,000 | 0.97% |
| Ghost Tree Capital, LLC | 150,000 | $3,158,000 | 0.92% |